Quality-of-care indicators for children with sickle cell disease

Pediatrics

Volumn 128, Issue 3, 2011, Pages 484-493

  Wang, C Jason ^a,b,c   Kavanagh, Patricia L ^a,b   Little, Alison A ^b   Holliman, Jaime Bruce ^b,c   Sprinz, Philippa G ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Quality indicators; Quality of care; Sickle cell disease

Indexed keywords

FOLIC ACID; HYDROXYUREA; PENICILLIN G;

ACUTE CORONARY SYNDROME; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASTHMA; BLOOD CELL COUNT; BLOOD TRANSFUSION; CHILD CARE; CHOLELITHIASIS; CONSENSUS DEVELOPMENT; DELPHI STUDY; EYE CARE; FEVER; GENETIC COUNSELING; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNIZATION; INFLUENZA; LUNG FUNCTION TEST; NEUROPSYCHOLOGICAL TEST; OSTEOMYELITIS; PAIN; PATIENT EDUCATION; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PRIAPISM; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SICKLE CELL ANEMIA; STROKE; VITAMIN SUPPLEMENTATION;

ANEMIA, SICKLE CELL; CHILD; DELPHI TECHNIQUE; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY INDICATORS, HEALTH CARE; QUALITY OF LIFE;

EID: 80052364835     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-1791     Document Type: Article

References (87)

1. American Academy of Pediatrics, Section on Hematology/Oncology Committee on Genetics. Health supervision for children with sickle cell disease. Pediatrics. 2002;109(3):526-535
2. Hassell K. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4):S512-S521
3. Centers for Disease Control and Prevention. Sickle cell disease (SCD): facts about SCD. 2009. Available at: www.cdc.gov/ncbddd/sicklecell/facts.html. Accessed March 23, 2010
4. Steinberg M.H. Management of sickle cell disease. N Engl J Med. 1999;340(13):1021-1030 (Pubitemid 29157635)
5. Ballas S.K., Lieff S., Benjamin L.J., et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol. 2010;85(1):6-13
6. Palermo T., Schwartz L., Drotar D., McGowan K. Parental report of health-related quality of life in children with sickle cell disease. J Behav Med. 2002;25(3):269-283 (Pubitemid 37486637)
7. Quinn C.T., Rogers Z.R., McCavit T.L., Buchanan G.R. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115(17):3447- 3452
8. Gaston M.H., Verter J.I., Woods G., et al. Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial. N Engl J Med. 1986;314:1593-1599 (Pubitemid 16118215)
9. Adamkiewicz T.V., Silk B.J., Howgate J., et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics. 2008;121(3):562-569
10. National Heart Lung and Blood Institute. The Management of Sickle Cell Disease. No. 02-2117. Bethesda, MD: National Institutes of Health; 2002
11. Adams R.J., McKie V.C., Hsu L., et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5-11 (Pubitemid 28304491)
12. Adams R., McKie V., Nichols F., et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326(9):605-610
13. Adams R.J., Brambilla D. Optimizing primary stroke prevention in sickle cell anemia trial I: Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353(26):2769-2778 (Pubitemid 43016816)
14. Fullerton H.J., Adams R.J., Zhao S., Johnston S.C. Declining stroke rates in Californian children with sickle cell disease. Blood. 2004;104(2):336-339 (Pubitemid 38900012)
15. Smith L.A., Oyeku S.O., Homer C., Zuckerman B. Sickle cell disease: A question of equity and quality. Pediatrics. 2006;117(5):1763-1770 (Pubitemid 46071409)
16. Platt O., Brambilla D., Rosse W., et al. Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-1644
17. Davis H., Gergen P.J., Moore R.M. Geographic differences in mortality of young children with sickle cell disease in the United States. Public Health Rep. 1997;112(1):52-58 (Pubitemid 27053115)
18. Brousseau D., Owens P., Mosso A., Panepinto J., Steiner C. Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 2010;303(13):1288-1294
19. Institute of Medicine, Committee on Quality Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001
20. Williams S., Schmaltz S., Morton D., Koss R., Loeb J. Quality of care in US hospitals as reflected by standardized measures, 2002-2004. N Engl J Med. 2005;353(3):255-264 (Pubitemid 41058325)
21. Marciniak T.A., Ellerbeck E.F., Radford M.J., et al. Improving the quality of care for Medicare patients with acute myocardial infarction: Results from the Cooperative Cardiovascular Project. JAMA. 1998;279(17):1351-1357 (Pubitemid 28198801)
22. Brook R., McGlynn E., Cleary P. Measuring quality of care: Part two of six. N Engl J Med. 1996;335(13):966-970 (Pubitemid 26314453)
23. Cheng S., Wang C., Lin J., et al. Adherence to quality indicators and survival in patients with breast cancer. Med Care. 2009;47(2):217-225
24. Higashi T., Shekelle P., Adams J., et al. Quality of care is associated with survival in vulnerable older patients. Ann Intern Med. 2005;143(4):274-281
25. Ashton C.M., Kuykendall D.H., Johnson M.L., Wray N.P., Wu L. The association between the quality of inpatient care and early readmission. Ann Intern Med. 1995;122(6):415-421
26. West S., King V., Carey T., et al. Systems to Rate the Strength of Scientific Evidence. Rockville, MD: Agency for Healthcare Research and Quality; 2002
27. McGlynn E., Damberg C., Kerr E., Schuster M. Quality of Care for Children and Adolescents. Santa Monica, CA: Rand; 2000
28. Brook R. The Rand/UCLA appropriateness method. In: McCormick K, Moore S, Siegel R, eds. Clinical Practice Guideline Development: Methodology Perspectives. Rockville, MD: Agency for Health Care Policy and Research; 1994
29. Shekelle P., Chassin M., Park R. Assessing the predictive validity of the Rand/UCLA appropriateness method criteria for performing carotid endarterectomy. Int J Technol Assess Health Care. 1998;14(4):707-727 (Pubitemid 29029300)
30. Kravitz R., Laouri M., Kahan J., et al. Validity of criteria used for detecting underuse of coronary revascularization. JAMA. 1995;274(8):632
31. Shekelle P., Kahan J., Bernstein S., Leape L., Kamberg C., Park R. The reproducibility of a method to identify the overuse and underuse of medical procedures. N Engl J Med. 1998;338(26):1888
32. Schuster M., Asch S., McGlynn E., Kerr E., Hardy A., Gifford D. Development of a quality of care measurement system for children and adolescents: Methodological considerations and comparisons with a system for adult women. Arch Pediatr Adolesc Med. 1997;151(11):1085-1092 (Pubitemid 27483917)
33. Fitch K., Bernstein S., Aguilar M., et al. The Rand/UCLA Appropriateness Method User's Manual. Santa Monica, CA: Rand Corporation. 2001
34. Brook R.H. The Rand/UCLA appropriateness method. In: McCormick KA, Moore SR, Siegel RA, eds. Clinical Practice Guideline Development: Methodology Perspectives. Rockville, MD: Agency for Health Care Policy and Research; 1994
35. Davis P.B. Cystic fibrosis since 1938. Am J Respir Crit Care Med. 2006;173:475-482
36. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation patient registry: annual data report 2008. Available at: www.cff.org/uploadedfiles/research/ clinicalresearch/2008-patient-registry-report.pdf. Accessed August 26, 2010
37. Ballas S.K., Dampier C. Outcome of transitioning pediatric patients with sickle cell disease to adult programs [abstr]. Blood. 2004;104(11): 3743
38. Hearnshaw H., Harker R., Cheater F., Baker R., Grimshaw G. Expert consensus on the desirable characteristics of review criteria for improvement of health care quality. Qual Health Care. 2001;10(3):173-178
39. McGlynn E., Asch S. Developing a clinical performance measure. Am J Prev Med. 1998;14(3):14-21 (Pubitemid 28175720)
40. Brawley O.W., Cornelius L.J., Edwards L.R., et al. National Institutes of Health Consensus Development Conference statement: Hydroxyurea treatment for sickle cell disease. Ann Intern Med. 2008;148(12):932-938 (Pubitemid 351860825)
41. National Diabetes Support Team. NICE and Diabetes: A Summary of Relevant Guidelines. London, United Kingdom: National Health Service; 2006
42. Campbell S.M., Cantrill J.A., Roberts D. Prescribing indicators for UK general practice: Delphi consultation study. BMJ. 2000;321(7258):425-429
43. Wang C.J., McGlynn E.A., Brook R.H., et al. Quality-of-Care indicators for the neurodevelopmental follow-up of very low birth weight children: Results of an expert panel process. Pediatrics. 2006;117(6):2080-2092 (Pubitemid 46071254)
44. McNaughton H., McPherson K., Taylor W., Weatherall M. Relationship between process and outcome in stroke care. Stroke. 2003;34(3):713-717 (Pubitemid 36307399)
45. Eshaghian S., Horwich T.B., Fonarow GC. An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J. 2006;151(1):91.e1-91.e6
46. Gæde P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580-591 (Pubitemid 351214285)
47. National Heart Lung and Blood Institute. For safety, NHLBI changes intensive blood sugar treatment strategy in clinical trial of diabetes and cardiovascular disease. Available at: http://public.nhlbi.nih.gov/newsroom/home/ GetPressRelease.aspx?id=2551. Accessed March 5, 2011
48. Boyd J.H., Macklin E.A., Strunk R.C., DeBaun M.R. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood. 2006;108(9):2923-2927
49. Boyd J.H., Macklin E.A., Strunk R.C., DeBaun M.R. Asthma is associated with increased mortality in individuals with sickle cell anemia. Haematologica. 2007;92(8):1115-1118 (Pubitemid 350144219)
50. Rees D.C., Olujohungbe A.D., Parker N.E., et al. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol. 2003;120(5):744-752 (Pubitemid 36315093)
51. Pass K.A., Lane P.A., Fernhoff P.M., et al. US newborn screening system guidelines II: Follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN). J Pediatr. 2000;137(suppl 4):S1-S46
52. Farrell M., Certain L., Farrell P. Genetic counseling and risk communication services of newborn screening programs. Arch Pediatr Adolesc Med. 2001;155(2):120-126 (Pubitemid 32128379)
53. Zemel B.S., Kawchak D.A., Ohene-Frempong K., Schall J.I., Stallings V.A. Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatr Res. 2007;61(5 pt 1):607-613 (Pubitemid 46650016)
54. Thomas P.W., Singhal A., Hemmings-Kelly M., Serjeant G.R. Height and weight reference curves for homozygous sickle cell disease. Arch Dis Child. 2000;82(3):204-208 (Pubitemid 30305670)
55. O'Brien K.L., Swift A.J., Winkelstein J.A., et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group. Pediatrics. 2000;106(5):965-972
56. Adamkiewicz T.V., Sarnaik S., Buchanan G.R., et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr. 2003;143(4):438-444 (Pubitemid 37352499)
57. Bundy D.G., Strouse J.J., Casella J.F., Miller M.R. Burden of influenza-related hospitalizations among children with sickle cell disease. Pediatrics. 2010;125(2):234-243
58. Overturf G.D.; American Academy of Pediatrics, Committee on Infectious Diseases. Technical report: Prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics. 2000;106(2 pt 1):367-376
59. Falletta J.M., Woods G.M., Verter J.I., et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II. J Pediatr. 1995;127(5):685-690
60. Mantadakis E., Cavender J.D., Rogers Z.R., Ewalt D.H., Buchanan G.R. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol. 1999;21(6):518-522 (Pubitemid 30305987)
61. Wang W., Enos L., Gallagher D., et al. Neuropsychologic performance in school-aged children with sickle cell disease: A report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139(3):391-397 (Pubitemid 32889516)
62. Thompson R.J. Jr, Gustafson K.E., Bonner M.J., Ware R.E. Neurocognitive development of young children with sickle cell disease through three years of age. J Pediatr Psychol. 2002;27(3):235-244 (Pubitemid 34298904)
63. Aygun B., Padmanabhan S., Paley C., Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion (Paris). 2002;42(1):37-43
64. Vichinsky E.P., Luban N.L., Wright E., et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: A multicenter transfusion trial. Transfusion (Paris). 2001;41(9):1086-1092 (Pubitemid 32848083)
65. Vichinsky E.P., Neumayr L.D., Earles A.N., et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group [erratum appears in N Engl J Med. 2000;343(11): 824]. N Engl J Med. 2000;342(25):1855-1865 (Pubitemid 30419049)
66. Neumayr L., Lennette E., Kelly D., et al. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics. 2003;112(1 pt 1):87-95 (Pubitemid 36792934)
67. Bellet P.S., Kalinyak K.A., Shukla R., Gelfand M.J., Rucknagel D.L. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med. 1995;333(11):699-703
68. Styles L.A., Vichinsky E.P. Core decompression in avascular necrosis of the hip in sickle-cell disease. Am J Hematol. 1996;52(2):103-107 (Pubitemid 26176565)
69. Hernigou P., Habibi A., Bachir D., Galacteros F. The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. J Bone Joint Surg Am. 2006;88(12):2565-2572 (Pubitemid 44901942)
70. Vichinsky E.P., Haberkern C.M., Neumayr L., et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995;333(4):206-213
71. Norris C.F., Smith-Whitley K., McGowan K.L. Positive blood cultures in sickle cell disease: Time to positivity and clinical outcome. J Pediatr Hematol Oncol. 2003;25(5):390-395 (Pubitemid 36569971)
72. West D.C., Andrada E., Azari R., Rangaswami A.A., Kuppermann N. Predictors of bacteremia in febrile children with sickle cell disease. J Pediatr Hematol Oncol. 2002;24(4):279-283 (Pubitemid 34506615)
73. Adams R.J., Brambilla D.J., Granger S., et al. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004;103(10):3689-3694 (Pubitemid 38596283)
74. Hankins J.S., Fortner G.L., McCarville M.B., et al. The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia. Br J Haematol. 2008;142(1):94-99 (Pubitemid 351783160)
75. Ashley-Koch A., Murphy C.C., Khoury M.J., Boyle C.A. Contribution of sickle cell disease to the occurrence of developmental disabilities: A population-based study. Genet Med. 2001;3(3):181-186
76. DeVeber G., Kirkham F. Guidelines for the treatment and prevention of stroke in children. Lancet Neurol. 2008;7(11):983-985
77. Bhogal S., Zemek R., Ducharme F. Written action plans for asthma in children. Cochrane Database Syst Rev. 2006;(3):CD005306
78. Pegelow C.H., Colangelo L., Steinberg M., et al. Natural history of blood pressure in sickle cell disease: Risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med. 1997;102(2):171-177 (Pubitemid 27122999)
79. Bernaudin F., Socie G., Kuentz M., et al. Long-term results of related myeloablative stemcell transplantation to cure sickle cell disease. Blood. 2007;110(7):2749-2756 (Pubitemid 47523201)
80. Walters M.C., Storb R., Patience M., et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report - Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood. 2000;95(6):1918-1924 (Pubitemid 30151626)
81. Walters M.C., Patience M., Leisenring W., et al. Bone marrow transplantation for sickle cell disease. N Engl J Med. 1996;335(6):369-376 (Pubitemid 26257244)
82. Ferster A., Vermylen C., Cornu G., et al. Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial. Blood. 1996;88(6):1960-1964 (Pubitemid 26307897)
83. Pegelow C.H., Adams R.J., McKie V., et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995;126(6):896-899
84. Adamkiewicz T.V., Abboud M.R., Paley C., et al. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood. 2009;114(21):4632-4638
85. Brown K., Subramony C., May W., et al. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy. J Pediatr Hematol Oncol. 2009;31(5):309-312
86. Files B., Brambilla D., Kutlar A., et al. Longitudinal changes in ferritin during chronic transfusion: A report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). J Pediatr Hematol Oncol. 2002;24(4):284-290 (Pubitemid 34506616)
87. Ware R.E., Rees R.C., Sarnaik S.A., et al. Renal function in infants with sickle cell anemia: Baseline data from the BABY HUG trial. J Pediatr. 2010;156(1):66-70